Tandlægeselskabet Svendborg I/S

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  0.5% 0.5% 0.5% 0.5% 0.5%  
Bankruptcy risk  1.1% 0.9% 1.3% 1.6% 1.7%  
Credit score (0-100)  86 88 79 73 72  
Credit rating  A A A A A  
Credit limit (kDKK)  154.4 361.0 61.7 15.9 8.9  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Net sales  0 0 0 0 0  
Gross profit  8,005 10,313 10,673 11,186 11,249  
EBITDA  4,380 5,449 5,266 5,687 5,272  
EBIT  3,934 4,998 4,815 5,234 4,799  
Pre-tax profit (PTP)  3,828.7 4,900.2 4,736.8 5,178.6 4,681.1  
Net earnings  3,828.7 4,900.2 4,736.8 5,178.6 4,681.1  
Pre-tax profit without non-rec. items  3,829 4,900 4,737 5,179 4,681  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Tangible assets total  2,068 1,830 1,592 1,467 1,205  
Shareholders equity total  0.0 0.0 0.0 5,179 4,681  
Interest-bearing liabilities  6,209 7,889 6,639 5,817 5,432  
Balance sheet total (assets)  7,245 8,913 7,356 6,440 6,149  

Net Debt  6,163 5,696 5,571 5,319 4,551  
 
See the entire balance sheet

Volume 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  8,005 10,313 10,673 11,186 11,249  
Gross profit growth  26.2% 28.8% 3.5% 4.8% 0.6%  
Employees  10 10 11 11 12  
Employee growth %  42.9% 0.0% 10.0% 0.0% 9.1%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  7,245 8,913 7,356 6,440 6,149  
Balance sheet change%  -3.3% 23.0% -17.5% -12.5% -4.5%  
Added value  4,379.6 5,449.2 5,266.1 5,685.1 5,272.4  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -839 -902 -902 -790 -948  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  2.0 3.0 4.0 5.0 5.0  

Profitability 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  49.1% 48.5% 45.1% 46.8% 42.7%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  53.4% 61.9% 59.2% 75.9% 76.3%  
ROI %  59.3% 69.9% 66.3% 84.1% 85.4%  
ROE %  52.0% 60.7% 58.2% 82.6% 95.0%  

Solidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Equity ratio %  0.0% 0.0% 0.0% 44.6% 43.3%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  140.7% 104.5% 105.8% 93.5% 86.3%  
Gearing %  0.0% 0.0% 0.0% 112.3% 116.0%  
Net interest  0 0 0 0 0  
Financing costs %  1.7% 1.5% 1.1% 0.9% 2.2%  

Liquidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Quick Ratio  0.1 0.4 0.3 0.2 0.3  
Current Ratio  0.2 0.4 0.3 0.3 0.3  
Cash and cash equivalent  46.0 2,193.0 1,068.4 497.7 881.5  

Capital use efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -5,810.9 -5,584.0 -5,133.2 -4,795.8 -4,321.9  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  438 545 479 517 439  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  438 545 479 517 439  
EBIT / employee  393 500 438 476 400  
Net earnings / employee  383 490 431 471 390